Novo Nordisk Fair Value
0Q
The fair market value of 0QIU.L stock is 682.7 DKK. Relative to the market price of 899.65 DKK Novo Nordisk A/S is overvalued by 23.3%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Novo Nordisk Valuation
Current 0QIU.L share ticker price is 899.65 DKK.
The fair value level of 682.7 DKK can be considered as an effective entry point for long-term investors to start investing in 0QIU.L stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 24% higher its fair value
Current price is 46% higher its minimum value
Current price is 12% higher its maximum value
Market price:
0QIU.L stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
Novo Nordisk A/S Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
30.19
2
Median P/E over 5 years
26.01
3
Minimum P/E over 5 years
18.42
4
Earning per share (last 12 months)
26.25 DKK
Maximum value
1
x
4
=
792.56 DKK
Fair value
2
x
4
=
682.7 DKK
Minimum value
3
x
4
=
483.51 DKK
Novo Nordisk A/S price metrics
40.7
Annual return (geometric mean)
27.9
Risk (standard deviation) of returns
β
1.4
Beta (volatility compared to market)